Evidence map›Paper›PMID 40469236›Full record

ArticleJID innovations : skin science from molecules to population health2025

Evaluation of Actinic Keratosis as a Risk Factor for Subsequent Nonskin Cancer Risk.

Alexander R Gomez-Lara, Christopher D George, Chen Jiang, Jie Yin, Yuhree Kim, Charles P Quesenberry, Eric Jorgenson, Shabnam Madani, Maryam M Asgari, Hélène Choquet

Abstract read
In one paragraph

Article in JID innovations : skin science from molecules to population health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexander R Gomez-LaraKaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Christopher D GeorgeDepartment of Dermatology, Stanford University School of Medicine, Palo Alto, California, USA.
Chen JiangDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, USA.
Jie YinDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, USA.
Yuhree KimDepartment of Dermatology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Charles P QuesenberryDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, USA.
Eric JorgensonRegeneron Genetics Center, Tarrytown, New York, USA.
Shabnam MadaniDepartment of Dermatology and Mohs Surgery, Kaiser Permanente, Walnut Creek, California, USA.
Maryam M AsgariDepartment of Dermatology, University of Colorado School of Medicine, Anschutz Medical Campus, Aurora, Colorado, USA.
Hélène ChoquetDivision of Research, Kaiser Permanente Northern California, Pleasanton, California, USA.

Funding

Patient-oriented research and mentoring program in dermatologic diseasesK24AR069760 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2017 to 2025
$1.9M
The Role of Genetic Risk Factors in Keratinocyte Carcinoma SusceptibilityR01CA241623 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI ASGARI, MARYAM MANDANA, CHOQUET, HELENE · 2020 to 2025
$1.7M
PQ3 Cutaneous squamous cell carcinoma: Integrating germline and somatic alterations that underlie tumor progressionR01CA231264 · NCI · UNIVERSITY OF COLORADO DENVER · PI ASGARI, MARYAM MANDANA · 2019 to 2023
$1.5M
NCI NIH HHS R01 CA231264NCI NIH HHS R01 CA241623NIAMS NIH HHS K24 AR069760
6 · The paper itself

Abstract

Actinic keratosis (AK) is a precancerous lesion that develops on chronically sun-exposed skin. Immunosuppression is known to increase the risk of both AK and other cancers, highlighting the need to evaluate potential associations between AK and subsequent nonskin cancers. To determine whether a diagnosis of AK is associated with an increased subsequent incident of nonskin cancers, we conducted a retrospective case-control study within a large integrated healthcare delivery system. The study included 53,778 patients with AK and 152,896 controls without prior cancer diagnoses at enrollment. AK was more prevalent in males (30.7 vs 23.5% in females). AK was not associated with increased risk of overall nonskin cancers after adjusting for demographic (age, sex), clinical (body mass index, immunosuppression history), behavioral (smoking, alcohol use), and healthcare utilization factors (adjusted hazard ratio = 0.99, 95% confidence interval = 0.95-1.02). However, significant associations were observed between AK and breast (adjusted hazard ratio = 1.11, 95% confidence interval = 1.03-1.19) and prostate (adjusted hazard ratio =1.14, 95% confidence interval = 1.03-1.26) cancers. This large study reveals that AK may be a predictor of risk for subsequent cancers, notably breast and prostate cancers. These findings emphasize the need for increased surveillance for these cancer types in individuals with AK.

Indexed as

ImmunosuppressionMalignancyPrecancerSurveillanceUVR

Identifiers

PMID40469236
PMCPMC12136887

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.